5/9
01:20 pm
anik
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $37.00 price target on the stock.
Low
Report
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $37.00 price target on the stock.
5/9
12:16 pm
anik
Rating for ANIK
Medium
Report
Rating for ANIK
3/14
10:14 am
anik
Rating for ANIK
Low
Report
Rating for ANIK
3/14
09:53 am
anik
Rating for ANIK
Low
Report
Rating for ANIK